| | RAD51D, RAD51L3-RFFL (I311N +2 more) | Single nucleotide variant (missense variant +1 more) | not specified +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided | |
| | RAD51D, RAD51L3-RFFL (K261T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (E233G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (R232Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast and/or ovarian cancer +4 more | |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Diffuse midline glioma, H3 K27-altered +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (R165Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (G68S) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | |
| | RAD51D, RAD51L3-RFFL (V66M) | Single nucleotide variant (missense variant +1 more) | RAD51D-related condition +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S46C) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |